Telix Pharmaceuticals Competitors and Similar CompaniesClear all

Telix Pharmaceuticals's competitors and similar companies include ASLAN Pharmaceuticals.

	Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.	ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
Type	Type Public	Type Private
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations North Melbourne, AU HQ Milton, AU Sydney, AU Herstal, BE Burnaby, CA Kyoto, JP Lancy, CH see more	Locations SG HQ Collingwood, AU
Employees	Employees 415	Employees 35
Financial
Revenue (est.)	Revenue (est.) $803.8m (FY, 2025)	Revenue (est.) $12m (FY, 2023)
Cost of goods	Cost of goods $356m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $449m (FY, 2025)	Gross profit $12m (FY, 2023)
Net income	Net income ($7.1m) (FY, 2025)	Net income ($44.2m) (FY, 2023)

For sources of this data, please see the company profile

Employees

ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.

Financial